(R)-N-methylnaltrexone, processes for its synthesis and its pharmaceutical use

Details for Australian Patent Application No. 2006249911 (hide)

Owner Progenics Pharmaceuticals, Inc.

Inventors Doshan, Harold D.; Perez, Julio

Agent Davies Collison Cave

Pub. Number AU-B-2006249911

PCT Pub. Number WO2006/127899

Priority 60/684,616 25.05.05 US

Filing date 25 May 2006

Wipo publication date 30 November 2006

Acceptance publication date 17 May 2012

International Classifications

C07D 489/08 (2006.01) Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61P 1/10 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/127899 Priority application(s): WO2006/127899

17 May 2012 Application Accepted

  Published as AU-B-2006249911

30 August 2012 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 09 Aug 2012 . Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006249921-Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) phenyl) ethylcarbamate

2006249910-(S)-N-methylnaltrexone, process for its synthesis and its pharmaceutical use